MMMagdalena Miernik-Skrzypczak

Magdalena Miernik-Skrzypczak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Magdalena Miernik-Skrzypczak has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparison of guidelines for diabetes diagnostics in 2019 and 2024 in Poland and the rights of insured persons to health services, including access to psychological care

    by Monika Kamińska, Magdalena Miernik-Skrzypczak, Marta Malicka, Patrycja Karnas-Bogacka, Katarzyna Moczyróg, Katarzyna Barwinek-Grajek, Aleksandra Błaszczyk

    This article compares diabetes diagnostics and treatment reimbursement in Poland between 2019 and 2024, highlighting the changes that occurred over these years. The review is based on an analysis of literature covering diabetes classification, diagnosis, complications, and current guidelines. Scientific articles, reviews, and relevant legislation were analyzed. Diagnostic guidelines highlight the use of glycated haemoglobin (HbA1c) and recommend genetic testing for neonatal diabetes. Reimbursements for diabetes treatment, particularly for modern devices and insulin pen needles, have improved. The 2024 guidelines highlight the importance of mental health, recommending regular psychological assessments. Guidelines have become more comprehensive, and reimbursement policies are more extensive, making access to essential therapies easier for patients. These changes aim at improving treatment outcomes and enhancing the quality of life.

  • Open Access

    The importance of stem cells in the treatment of type 1 diabetes, type 2 diabetes and diabetes complications

    by Monika Kamińska, Maria Jasiewicz, Magdalena Miernik-Skrzypczak, Aleksandra Spyra, Marta Malicka, Natalia Dąbrowska, Aleksandra Kozioł, Katarzyna Moczyróg

    Introduction and Purpose. Diabetes, characterized by hyperglycemia due to impaired insulin production or action, leads to significant complications like diabetic retinopathy (DR) and diabetic foot syndrome (DFS). Current treatments manage symptoms but do not fully address disease progression. Stem cells, with their regenerative potential and immunomodulatory properties, represent a promising avenue for treating diabetes and its complications. This study explores the use of stem cell therapy in managing type 1 and type 2 diabetes, DR, and DFS. Material and Method. The study reviewed existing literature on the application of stem cells in diabetes treatment. More than 30 articles addressing these issues were analyzed. They were found using the PubMed search engine, and the time frame of these publications covered the last 20 years. Results. Stem cells demonstrated significant potential in diabetes management. For type 1 diabetes, MSCs reduced inflammation, preserved pancreatic islet function, and decreased insulin requirements without major adverse effects. Pluripotent stem cells showed promise in islet transplantation, achieving stable glycemic control in clinical trials. In type 2 diabetes, stem cell therapy improved insulin sensitivity and reduced insulin dependency, with evidence of β-cell regeneration. Complications like diabetic foot ulcers and retinopathy also responded positively to stem cell treatments. MSCs improved wound healing by enhancing tissue regeneration and reducing inflammation, while retinal therapies showed promise in slowing disease progression and repairing damaged vasculature. Conclusions. Stem cell therapies offer a promising approach for diabetes and its complications, particularly for regenerative applications in DR and DFS. While initial results are encouraging, further large-scale studies are needed to optimize protocols, assess long-term safety, and establish standardized clinical applications.


  • Open Access

    Vitamin D Supplementation in Selected Autoimmune Diseases

    by Monika Kamińska, Aleksandra Kozioł, Magdalena Agata Miernik-Skrzypczak, Natalia Dąbrowska, Adrian Uchto, Patrycja Karnas-Bogacka, Marta Katarzyna Malicka, Maria Jasiewicz, Katarzyna Moczyróg

    Introduction and Objective. In recent years, awareness of the problem of vitamin D deficiency in the human body has been steadily increasing. There is a growing emphasis on investigating the effects of vitamin D supplementation both in the prevention of autoimmune diseases and in the course of existing diseases. The aim of this study is to highlight and discuss the role of vitamin D supplementation in selected autoimmune diseases.Review methods. The publication is a narrative review. The PubMed electronic database was used to review the literature. To ensure the highest substantive value, the focus was mainly on studies from the last 8 years, with only 6 studies published before 2016, concerning autoimmune diseases.Results. There are still lots of unknowns when it comes to physiology and the role that vitamin D plays in our body and deepening the knowledge of its functions would definitely help prevent many diseases concerning various systems such as musculoskeletal, immune and nervous systems. Wide range of studies have already proven that appropriate supplementation of vitamin D prevents complications and exacerbations of disorders like rheumatoid arthritis, Hashimoto’s thyroiditis, ulcerative colitis, type 1 diabetes and multiple sclerosis. Unfortunately there is no unambiguous evidence of noticeable improvement in the patients suffering from psoriasis after taking vitamin D. There is a huge need for developing guidelines which would establish specific supplementation protocols considering various factors since it is inexplicably difficult to obtain an optimal level of vitamin D in our body.Summary. The increasing prevalence of autoimmune diseases in the population, their coexistence with vitamin D deficiency, and the scientifically proven impact of this vitamin on the body imply the need for an in-depth analysis of the relationship between its supplementation and the prevention and modification of the course of autoimmune diseases.

  • Open Access

    The Impact of Nutritional and Dietary Factors on Hashimoto's Thyroiditis: A Comprehensive Review

    by Zuzanna Rybka, Monika Kamińska, Katarzyna Moczyróg, Patrycja Karnas-Bogacka, Adrian Uchto, Natalia Dąbrowska, Kaja Marszałek-Moc, Magdalena Miernik-Skrzypczak, Maria Jasiewicz, Karolina Alicja Palacz

    Introduction. Hashimoto's disease (HD) is the main cause of hypothyroidism in countries where there is no iodine deficiency in the diet. Characteristic antibodies for it are anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin (anti-Tg) and their level positively correlates with the severity of HD. Whereas its occurrence is related to genetic, environmental and existential factors. Aim of study. The aim of this study was to analyze dietary factors (protein, fat, vitamin D, iodine, selenium, gluten) and intestinal microbiota on the risk of developing Hashimoto's disease and the influence of each of these factors on its course. Materials and methods. More than 90 articles addressing these issues were analyzed. They were found using the PubMed search engine, and the time frame of these publications covered the last 10 years. Results. Excess iodine is the most important environmental factor influencing the development of Hashimoto's disease. Also, selenium deficiency contributes to the development of HD. On the other hand, the concentration of vitamin D is lower in patients with Hashimoto's disease than in the general population. Furthermore, Vitamin D supplementation reduces the concentration of anti-Tg antibodies. In addition, different types of dietary fat affect thyroid hormone levels differently and a deficiency of protein in the diet causes an increase in TSH and a decrease in thyroid hormones. Moreover, changes in the gut microbiome have been observed in people suffering from Hashimoto's disease. Conclusions. The risk of developing Hashimoto's disease can be increased and decreased by diet and diet allows for the modification of hormone levels in the hypothalamus-pituitary-thyroid axis.


  • Open Access

    Retrospective Analysis of Reasons for Presenting to Emergency Ophthalmic Care in Poland and the USA – Literature Review

    by Aneta Michalczewska, Kaja Marszałek-Moc, Karolina Alicja Palacz, Magdalena Miernik-Skrzypczak, Maria Jasiewicz, Monika Kamińska, Patrycja Karnas-Bognacka, Natalia Dąbrowska

    Introduction. Emergency Department is a hospital unit, where is provided care in in cases of sudden threat to life and health. One of the reasons why patients come to the Emergency Department is eye damage. Emergency ophthalmological services are a very important form of ophthalmological care because some conditions and diseases require quick intervention to prevent permanent vision damage or eye loss. Patients come to hospital emergency departments for many reasons, such as: eyeball injury, sudden pain or unexpected deterioration of vision. It is worth noting that some patients do not understand the provision of services within health care units and in conditions that do not require urgent care, they seek it in emergency rooms. Aim of study. The following study analyzes the reasons for reporting to emergency ophthalmological services in Poland and the United States. Knowing the most common causes of patients' ailments and the factors that influence them, we can plan strategies for providing specific services within health care units. Materials and methods. The work reviews articles published in the years 2005-2023 in Poland and the United States of America. The results obtained from individual studies were divided in terms of age, gender, traumatic and non-traumatic causes. Additionally, it was checked how often patients had to be hospitalized after staying in Polish emergency departments. Conclusions. Injuries and other eye diseases affect patients regardless of gender and age. Most often, these are adult men.